Western blot data demonstrating successful knockdown of Insulin Receptor in human cells approximately 72 hours after treatment with QX51 siRNA (SC = Scrambled Control (Product Number QC1), siRNA = QX51 treatment)
Western blot data demonstrating successful knockdown of Insulin Receptor in human cells approximately 72 hours after treatment with QX51 siRNA (SC = Scrambled Control (Product Number QC1), siRNA = QX51 treatment)

TranslationBlocker Human Insulin Receptor siRNA – DISCONTINUED

$ 219.00$ 329.00
Please Select Product Options Below To View The Catalog Number.

Human Insulin Receptor siRNA Translation Blocker™ Duplex

Product NumberDescriptionPrice
QX51-2nmol Size: 2 nmol, Tag: Untagged (Native Protein) $ 219.00
QX51-10nmol Size: 10 nmol, Tag: Untagged (Native Protein) $ 329.00
Shipping Information
Flat Rate Shipping Anywhere in the US: $45
Datasheets and Documentation
Product Datasheet
Certificate of Analysis and Tags (Coming Soon)
Lot Number:

Expiration Date:

Concentration (Write Lyophilized if Lyophilized):

Reconsitution Instructions (Leave Blank if Liquid):

Manufacture Date:


Bioactivity (test results eg. IU/ml):

SKU: QX51-2nmol

DISCONTINUED: Human Insulin Receptor TranslationBlocker™ siRNA Duplex Product Attributes

Blocks transcription and translation of Insulin Receptor from: Human.
May also react with Insulin Receptor based upon sequence homology and clone specific publications.
Type of RNAi: siRNA.
siRNA target sequence: NM_000208.
Samples and cell lines tested: HepG2 Human Hepatocellular Carcinoma Cells.
Buffer and Stabilizer: Lyophilized. See datasheet for resuspension instructions and buffer information.
Concentration of Anti-Human Insulin Receptor: Lyophilized
SiRNA Purification Method:RPC/HPLC
Storage Conditions: Store Lyophilized siRNA duplex at 4C. Reconsituted product may be stored at -20C for up to 1 month.
Insulin Receptor Knockdown Protocol:
    1. Starting with cultured cells in growth media seed plates with cells and incubated at 37°C. For instance, seed 6 well plates with 2x105 cells in growth media and incubate at 37°C until cells reach 40% confluence. Transfection reagents may specify the desired level of confluence to look for prior to starting transfections.
    2. The above data was generated with N-TER nanoparticle transfection agent in accordance with manufacturer’s instructions. Prepare transfection reagent in antibiotic-free growth medium. For other transfection reagents, serum-free media may be required. Allow to come to room temperature. </ li>
    3. Dilute siRNA to working concentration in antibiotic-free growth media. For N-TER or similar transfections into 6 well plates, we recommend starting siRNA dose optimization at approximately 75-100 pmol siRNA duplex.Optimal dilution should be experimentally determined.
    4. Combine diluted siRNA and transfection reagent according to manufacturer’s instructions. Ratio of transfection reagent to siRNA should be optimized.
    5. Add prepared siRNA solution to cells. For 6 well plates this will entail adding the solution to cells in approximately 2.5 ml serum-free medium. Optionally, FITC labeled control siRNA (Product Number QC-1F) or positive control siRNA (Beta-Actin; Product Number QC-2) may be used to assess transfection efficiency.
    6. Incubate and assay well after transfection. Optimal knockdown time should also be experimentally determined. Optionally, a second transfection can be performed 24 hours after the first transfection to enhance knockdown. Insulin Receptor knockdown at the protein level was measured at 72 hours post transfection via Western Blot.

Insulin Receptor General Information

Gene Name: Insr
Entrez Gene ID: 3643
NCBI Ref Seq Accession Number: NP_000199
Uniprot ID:
Insulin Receptor Molecular Weight:
Alternate Names: InsR, IR, CD220

Limitations and Warranty

This product is for Research Use Only. This product is guaranteed to work for a period of two years when stored at -70C or colder, and one year when aliquoted and stored at -20C.

There are no reviews yet.

Be the first to review “TranslationBlocker Human Insulin Receptor siRNA – DISCONTINUED”

Your email address will not be published. Required fields are marked *

Share a Protocol (View Reviewed Protocols Below)

Protocol Title




  protocol submission gif
enQuire Bio, LLC   8420 S Continental Divide Rd, #202   Littleton, CO 80127
Chat: See lower right corner. | enquire@enquirebio.com | Fax: 1-720-897-3730
Customer Service Available M-F 8AM-6PM MST or 24/7 Via Email

TranslationBlocker Human Insulin Receptor siRNA - DISCONTINUED